Adenosine 2A receptor drives microglial efferocytosis to accelerate white matter repair and functional recovery after stroke.
Although reperfusion therapy effectively restores blood flow to occluded brain arteries after ischemic stroke, many patients develop persistent white matter injury, a major contributor to long-term neurological disability. Currently, there are few approved clinical therapies that specifically target white matter repair...